Thanks for emailing that article!
The goal of Catalyst for a Cure research collaboration - funded by Glaucoma Research Foundation - is to discover clinically applicable biomarkers for the detection, monitoring and treatment of glaucoma.
The consortium has defined several early target milestones and work toward those milestones in now fully underway:
Progress toward these goals has been steady. All four labs are now fully established and running experiments. The four principal investigators talk regularly to discuss progress and members of the various groups travel to each other’s labs to carry out and discuss collaborative experiments.
Some key findings have emerged from these efforts that direct the focus for the next phase of experiments.
Together, these approaches incorporate the expertise of all four laboratories and maximize the benefits of collaboration.
The Catalyst for a Cure principal investigators are, from left to right: Alfredo Dubra, PhD (The Eye Institute, Medical College of Wisconsin), Andrew Huberman, PhD (University of California, San Diego), Jeffrey L. Goldberg, MD, PhD (Shiley Eye Center, UC San Diego), and Vivek Srinivasan, PhD (University of California, Davis).
Last reviewed on October 29, 2017
This article appeared in the January 2014 issue of Gleams.Subscribe